S-phase arrest after vincristine treatment may promote hepatitis B virus replication
AIM:To observe the effect of vincristine on hepatitis B virus(HBV) replication in vitro and to study its possible mechanisms.METHODS:Vincristine was added to the cultures of two cell lines stably expressing HBV.Then,the levels of hepatitis B surface antigen(HBs Ag),hepatitis B e antigen(HBe Ag),and...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 21; no. 5; pp. 1498 - 1509 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
07.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | AIM:To observe the effect of vincristine on hepatitis B virus(HBV) replication in vitro and to study its possible mechanisms.METHODS:Vincristine was added to the cultures of two cell lines stably expressing HBV.Then,the levels of hepatitis B surface antigen(HBs Ag),hepatitis B e antigen(HBe Ag),and hepatitis B core antigen(HBc Ag) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot.The HBV pregenome RNA(pg RNA) was detected using reverse transcription-PCR and realtime fluorescent quantitative PCR(RT-q PCR),and viral DNA was detected using Southern blot and RT-q PCR.Cell proliferation after drug treatment was detected using the Brd U incorporation test and the trypan blue exclusion assay.Cell cycle and cell apoptosis were examined using flow cytometry and Western blot.RESULTS:Vincristine up-regulated HBV replication directly in vitro in a dose-dependent manner,and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA,respectively.The expression of HBV pg RNA,intracellular HBs Ag and HBc Ag,and the secretion of HBe Ag were also increased significantly after drug treatment.Most importantly,vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles,and the nucleocapsids are closely related to the HBV pathogenesis.Furthermore,vincristine inhibited the proliferation of cells stably expressing HBV.The higher the concentration of the drug,the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells.Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition.CONCLUSION:Vincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest,and cell proliferation inhibition may be conducive to viral replication. |
---|---|
AbstractList | AIM:To observe the effect of vincristine on hepatitis B virus(HBV) replication in vitro and to study its possible mechanisms.METHODS:Vincristine was added to the cultures of two cell lines stably expressing HBV.Then,the levels of hepatitis B surface antigen(HBs Ag),hepatitis B e antigen(HBe Ag),and hepatitis B core antigen(HBc Ag) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot.The HBV pregenome RNA(pg RNA) was detected using reverse transcription-PCR and realtime fluorescent quantitative PCR(RT-q PCR),and viral DNA was detected using Southern blot and RT-q PCR.Cell proliferation after drug treatment was detected using the Brd U incorporation test and the trypan blue exclusion assay.Cell cycle and cell apoptosis were examined using flow cytometry and Western blot.RESULTS:Vincristine up-regulated HBV replication directly in vitro in a dose-dependent manner,and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA,respectively.The expression of HBV pg RNA,intracellular HBs Ag and HBc Ag,and the secretion of HBe Ag were also increased significantly after drug treatment.Most importantly,vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles,and the nucleocapsids are closely related to the HBV pathogenesis.Furthermore,vincristine inhibited the proliferation of cells stably expressing HBV.The higher the concentration of the drug,the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells.Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition.CONCLUSION:Vincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest,and cell proliferation inhibition may be conducive to viral replication. To observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms.AIMTo observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms.Vincristine was added to the cultures of two cell lines stably expressing HBV. Then, the levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot. The HBV pregenome RNA (pgRNA) was detected using reverse transcription-PCR and real-time fluorescent quantitative PCR (RT-qPCR), and viral DNA was detected using Southern blot and RT-qPCR. Cell proliferation after drug treatment was detected using the BrdU incorporation test and the trypan blue exclusion assay. Cell cycle and cell apoptosis were examined using flow cytometry and Western blot.METHODSVincristine was added to the cultures of two cell lines stably expressing HBV. Then, the levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot. The HBV pregenome RNA (pgRNA) was detected using reverse transcription-PCR and real-time fluorescent quantitative PCR (RT-qPCR), and viral DNA was detected using Southern blot and RT-qPCR. Cell proliferation after drug treatment was detected using the BrdU incorporation test and the trypan blue exclusion assay. Cell cycle and cell apoptosis were examined using flow cytometry and Western blot.Vincristine up-regulated HBV replication directly in vitro in a dose-dependent manner, and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA, respectively. The expression of HBV pgRNA, intracellular HBsAg and HBcAg, and the secretion of HBeAg were also increased significantly after drug treatment. Most importantly, vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles, and the nucleocapsids are closely related to the HBV pathogenesis. Furthermore, vincristine inhibited the proliferation of cells stably expressing HBV. The higher the concentration of the drug, the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells. Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition.RESULTSVincristine up-regulated HBV replication directly in vitro in a dose-dependent manner, and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA, respectively. The expression of HBV pgRNA, intracellular HBsAg and HBcAg, and the secretion of HBeAg were also increased significantly after drug treatment. Most importantly, vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles, and the nucleocapsids are closely related to the HBV pathogenesis. Furthermore, vincristine inhibited the proliferation of cells stably expressing HBV. The higher the concentration of the drug, the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells. Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition.Vincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest, and cell proliferation inhibition may be conducive to viral replication.CONCLUSIONVincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest, and cell proliferation inhibition may be conducive to viral replication. To observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms. Vincristine was added to the cultures of two cell lines stably expressing HBV. Then, the levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot. The HBV pregenome RNA (pgRNA) was detected using reverse transcription-PCR and real-time fluorescent quantitative PCR (RT-qPCR), and viral DNA was detected using Southern blot and RT-qPCR. Cell proliferation after drug treatment was detected using the BrdU incorporation test and the trypan blue exclusion assay. Cell cycle and cell apoptosis were examined using flow cytometry and Western blot. Vincristine up-regulated HBV replication directly in vitro in a dose-dependent manner, and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA, respectively. The expression of HBV pgRNA, intracellular HBsAg and HBcAg, and the secretion of HBeAg were also increased significantly after drug treatment. Most importantly, vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles, and the nucleocapsids are closely related to the HBV pathogenesis. Furthermore, vincristine inhibited the proliferation of cells stably expressing HBV. The higher the concentration of the drug, the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells. Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition. Vincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest, and cell proliferation inhibition may be conducive to viral replication. AIM: To observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms. METHODS: Vincristine was added to the cultures of two cell lines stably expressing HBV. Then, the levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot. The HBV pregenome RNA (pgRNA) was detected using reverse transcription-PCR and real-time fluorescent quantitative PCR (RT-qPCR), and viral DNA was detected using Southern blot and RT-qPCR. Cell proliferation after drug treatment was detected using the BrdU incorporation test and the trypan blue exclusion assay. Cell cycle and cell apoptosis were examined using flow cytometry and Western blot. RESULTS: Vincristine up-regulated HBV replication directly in vitro in a dose-dependent manner, and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA, respectively. The expression of HBV pgRNA, intracellular HBsAg and HBcAg, and the secretion of HBeAg were also increased significantly after drug treatment. Most importantly, vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles, and the nucleocapsids are closely related to the HBV pathogenesis. Furthermore, vincristine inhibited the proliferation of cells stably expressing HBV. The higher the concentration of the drug, the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells. Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition. CONCLUSION: Vincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest, and cell proliferation inhibition may be conducive to viral replication. |
Author | Lei Xu Zeng Tu Ge Xu Jie-Li Hu Xue-Fei Cai Xing-Xing Zhan Yu-Wei Wang Yuan Huang Juan Chen Ai-Long Huang |
AuthorAffiliation | Key Laboratory of Molecular Biology on Infectious Diseases,Ministry of Education,Chongqing Medical University Department of Microbiology,Chongqing Medical University Department of Pediatrics,Chongqing Medical University |
Author_xml | – sequence: 1 givenname: Lei surname: Xu fullname: Xu, Lei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25663769$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1rHCEYlpKSbNKceysee5mNn6NeCm3oFwR6aHoWx3F2DTM6UXdD_n2dZru0OUQQX_T5eH2fc3ASYnAAvMVoTQWTVw93m_We4LXna8yUfAVWhGDVEMnQCVhhhESjKBFn4DznO4QIpZycgjPC25aKVq3A7c9m3prsoEnJ5QLNUFyCex9s8rn44GBJzpTJhQIn8wjnFKdYHNy62RRffIafKjrtMkxuHr2tlzG8Aa8HM2Z3eTgvwK8vn2-vvzU3P75-v_5401hGRWk4H1QvmeFIYKE6jvoec8yFIKgfOmKNVV0vydAjpIRgqHUt7YVwncWWMGXpBfjwpDvvusn1tjaZzKjn5CeTHnU0Xv__EvxWb-JeM4pbpEgVeH8QSPF-V_-vJ5-tG0cTXNxljVtOMZGCtxX67l-vo8nfUVbA1RPApphzcsMRgpFewtI1LF3D0p7rJazK4M8Y1pc_A6zN-vEFHj3wtjFs7n3YHK0UkstSHDHJFKdMLnup6G9d1au8 |
CitedBy_id | crossref_primary_10_1038_s41598_018_21847_3 crossref_primary_10_3390_pathogens14020203 crossref_primary_10_1016_j_antiviral_2017_06_005 crossref_primary_10_1016_j_yexcr_2015_07_021 crossref_primary_10_1089_ars_2022_0144 crossref_primary_10_14218_JCTH_2020_00105 crossref_primary_10_1134_S0026893322050041 crossref_primary_10_3390_v11110997 crossref_primary_10_3390_insects12121098 |
Cites_doi | 10.1186/1743-422X-8-231 10.3748/wjg.v17.i12.1531 10.1038/sj.bjc.6601699 10.1016/0016-5085(91)90599-G 10.1016/j.virol.2010.07.030 10.1097/00007890-199204000-00034 10.1016/j.virol.2010.07.042 10.1016/S0140-6736(75)90897-1 10.1016/0270-9139(95)90350-X 10.1128/JVI.66.7.4107-4116.1992 10.1016/j.bbrc.2012.01.066 10.1007/s00277-007-0396-1 10.1073/pnas.84.4.1005 10.1146/annurev.iy.13.040195.000333 10.1128/JVI.00505-06 10.1016/j.taap.2007.11.032 10.1002/hep.22106 10.1016/j.jsb.2012.10.004 10.1111/j.1440-1746.2010.06243.x 10.1111/j.1440-1746.1998.tb00539.x 10.1073/pnas.1003854107 10.1002/jmv.10430 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0 10.1073/pnas.83.6.1627 |
ContentType | Journal Article |
Copyright | The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015 |
Copyright_xml | – notice: The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015 |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.3748/wjg.v21.i5.1498 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | S-phase arrest after vincristine treatment may promote hepatitis B virus replication |
EISSN | 2219-2840 |
EndPage | 1509 |
ExternalDocumentID | PMC4316092 25663769 10_3748_wjg_v21_i5_1498 90888889504849534853484953 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 123 29R 2B. 2C~ 2RA 2WC 36B 53G 5VR 8WL 92F 92I 92L 93N 93R AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CQIGP CS3 CW9 DIK DU5 E3Z EBS EJD EMB F5P FA0 FRP GX1 HYE M~E OK1 P2P RNS RPM SV3 TCJ TGQ TR2 W91 WFFXF XSB ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c437t-55f9d84a507179b50dd15157720dfb2cac9bd82fd00977406e63d77ebc1c249c3 |
ISSN | 1007-9327 2219-2840 |
IngestDate | Thu Aug 21 14:14:19 EDT 2025 Fri Jul 11 09:08:05 EDT 2025 Thu Apr 03 07:06:07 EDT 2025 Tue Jul 01 01:53:49 EDT 2025 Thu Apr 24 23:03:30 EDT 2025 Wed Feb 14 10:21:12 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Keywords | Cytotoxic chemotherapy Cell cycle arrest Hepatitis B virus Proliferation Viral reactivation |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c437t-55f9d84a507179b50dd15157720dfb2cac9bd82fd00977406e63d77ebc1c249c3 |
Notes | Viral reactivation;Cytotoxic chemotherapy;Cell cyc AIM:To observe the effect of vincristine on hepatitis B virus(HBV) replication in vitro and to study its possible mechanisms.METHODS:Vincristine was added to the cultures of two cell lines stably expressing HBV.Then,the levels of hepatitis B surface antigen(HBs Ag),hepatitis B e antigen(HBe Ag),and hepatitis B core antigen(HBc Ag) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot.The HBV pregenome RNA(pg RNA) was detected using reverse transcription-PCR and realtime fluorescent quantitative PCR(RT-q PCR),and viral DNA was detected using Southern blot and RT-q PCR.Cell proliferation after drug treatment was detected using the Brd U incorporation test and the trypan blue exclusion assay.Cell cycle and cell apoptosis were examined using flow cytometry and Western blot.RESULTS:Vincristine up-regulated HBV replication directly in vitro in a dose-dependent manner,and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA,respectively.The expression of HBV pg RNA,intracellular HBs Ag and HBc Ag,and the secretion of HBe Ag were also increased significantly after drug treatment.Most importantly,vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles,and the nucleocapsids are closely related to the HBV pathogenesis.Furthermore,vincristine inhibited the proliferation of cells stably expressing HBV.The higher the concentration of the drug,the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells.Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition.CONCLUSION:Vincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest,and cell proliferation inhibition may be conducive to viral replication. Lei Xu;Zeng Tu;Ge Xu;Jie-Li Hu;Xue-Fei Cai;Xing-Xing Zhan;Yu-Wei Wang;Yuan Huang;Juan Chen;Ai-Long Huang;Key Laboratory of Molecular Biology on Infectious Diseases,Ministry of Education,Chongqing Medical University;Department of Microbiology,Chongqing Medical University;Department of Pediatrics,Chongqing Medical University ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Telephone: +86-23-68486780 Fax: +86-23-68486780 Correspondence to: Ai-Long Huang, Professor, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, No. 1 Yixueyuan Road, Chongqing 400016, China. ahuang@cqu.edu.cn Author contributions: Xu L performed the majority of the experiments; Tu Z, Xu G, Hu JL and Cai XF made substantial contributions in conceiving and designing the study; Zhan XX, Wang YW and Huang Y contributed to the analysis and interpretation of the data; Chen J and Huang AL designed the study; Huang AL provided financial support for this work. |
OpenAccessLink | https://www.wjgnet.com/1007-9327/full/v21/i5/1498.htm |
PMID | 25663769 |
PQID | 1653128756 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4316092 proquest_miscellaneous_1653128756 pubmed_primary_25663769 crossref_primary_10_3748_wjg_v21_i5_1498 crossref_citationtrail_10_3748_wjg_v21_i5_1498 chongqing_primary_90888889504849534853484953 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-02-07 |
PublicationDateYYYYMMDD | 2015-02-07 |
PublicationDate_xml | – month: 02 year: 2015 text: 2015-02-07 day: 07 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | World journal of gastroenterology : WJG |
PublicationTitleAlternate | World Journal of Gastroenterology |
PublicationYear | 2015 |
Publisher | Baishideng Publishing Group Inc |
Publisher_xml | – name: Baishideng Publishing Group Inc |
References | ref13 ref12 ref15 ref14 ref11 ref10 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref8 ref7 ref9 ref4 ref3 ref6 ref5 16912290 - J Virol. 2006 Sep;80(17):8390-401 1602535 - J Virol. 1992 Jul;66(7):4107-16 3029758 - Proc Natl Acad Sci U S A. 1987 Feb;84(4):1005-9 21472116 - World J Gastroenterol. 2011 Mar 28;17(12):1531-7 23079477 - J Struct Biol. 2013 Jan;181(1):53-60 51345 - Lancet. 1975 Sep 20;2(7934):528-30 15054446 - Br J Cancer. 2004 Apr 5;90(7):1306-11 18201741 - Toxicol Appl Pharmacol. 2008 Apr 1;228(1):93-104 21670970 - Hepatol Int. 2013 Jun;7(2):316-26 3006059 - Proc Natl Acad Sci U S A. 1986 Mar;83(6):1627-31 21575146 - Virol J. 2011;8:231 15567742 - Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):543-7 20705311 - Virology. 2010 Oct 25;406(2):280-5 15517913 - Anticancer Res. 2004 Sep-Oct;24(5A):3035-40 20546439 - J Gastroenterol Hepatol. 2010 May;25(5):864-71 9737566 - J Gastroenterol Hepatol. 1998 Jan;13(1):14-20 20421498 - Proc Natl Acad Sci U S A. 2010 May 11;107(19):8766-71 7612225 - Annu Rev Immunol. 1995;13:29-60 1983820 - Gastroenterology. 1991 Jan;100(1):182-8 1566355 - Transplantation. 1992 Apr;53(4):894-8 7601429 - Hepatology. 1995 Jul;22(1):36-43 12774010 - Hepatology. 2003 Jun;37(6):1320-8 22290227 - Biochem Biophys Res Commun. 2012 Feb 24;418(4):641-6 11055239 - J Med Virol. 2000 Nov;62(3):299-307 20719353 - Virology. 2010 Nov 10;407(1):14-25 18302293 - Hepatology. 2008 Mar;47(3):844-53 |
References_xml | – ident: ref23 doi: 10.1186/1743-422X-8-231 – ident: ref13 doi: 10.3748/wjg.v17.i12.1531 – ident: ref14 doi: 10.1038/sj.bjc.6601699 – ident: ref16 doi: 10.1016/0016-5085(91)90599-G – ident: ref12 doi: 10.1016/j.virol.2010.07.030 – ident: ref19 doi: 10.1097/00007890-199204000-00034 – ident: ref24 doi: 10.1016/j.virol.2010.07.042 – ident: ref7 doi: 10.1016/S0140-6736(75)90897-1 – ident: ref20 doi: 10.1016/0270-9139(95)90350-X – ident: ref8 doi: 10.1128/JVI.66.7.4107-4116.1992 – ident: ref10 doi: 10.1016/j.bbrc.2012.01.066 – ident: ref6 doi: 10.1007/s00277-007-0396-1 – ident: ref11 doi: 10.1073/pnas.84.4.1005 – ident: ref3 doi: 10.1146/annurev.iy.13.040195.000333 – ident: ref25 doi: 10.1128/JVI.00505-06 – ident: ref9 doi: 10.1016/j.taap.2007.11.032 – ident: ref17 doi: 10.1002/hep.22106 – ident: ref22 doi: 10.1016/j.jsb.2012.10.004 – ident: ref26 – ident: ref2 doi: 10.1111/j.1440-1746.2010.06243.x – ident: ref5 doi: 10.1111/j.1440-1746.1998.tb00539.x – ident: ref18 – ident: ref21 doi: 10.1073/pnas.1003854107 – ident: ref1 doi: 10.1002/jmv.10430 – ident: ref15 doi: 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0 – ident: ref4 doi: 10.1073/pnas.83.6.1627 – reference: 7612225 - Annu Rev Immunol. 1995;13:29-60 – reference: 20546439 - J Gastroenterol Hepatol. 2010 May;25(5):864-71 – reference: 20705311 - Virology. 2010 Oct 25;406(2):280-5 – reference: 12774010 - Hepatology. 2003 Jun;37(6):1320-8 – reference: 1566355 - Transplantation. 1992 Apr;53(4):894-8 – reference: 7601429 - Hepatology. 1995 Jul;22(1):36-43 – reference: 21472116 - World J Gastroenterol. 2011 Mar 28;17(12):1531-7 – reference: 23079477 - J Struct Biol. 2013 Jan;181(1):53-60 – reference: 9737566 - J Gastroenterol Hepatol. 1998 Jan;13(1):14-20 – reference: 15517913 - Anticancer Res. 2004 Sep-Oct;24(5A):3035-40 – reference: 11055239 - J Med Virol. 2000 Nov;62(3):299-307 – reference: 15567742 - Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):543-7 – reference: 22290227 - Biochem Biophys Res Commun. 2012 Feb 24;418(4):641-6 – reference: 1602535 - J Virol. 1992 Jul;66(7):4107-16 – reference: 18302293 - Hepatology. 2008 Mar;47(3):844-53 – reference: 20719353 - Virology. 2010 Nov 10;407(1):14-25 – reference: 1983820 - Gastroenterology. 1991 Jan;100(1):182-8 – reference: 15054446 - Br J Cancer. 2004 Apr 5;90(7):1306-11 – reference: 21670970 - Hepatol Int. 2013 Jun;7(2):316-26 – reference: 20421498 - Proc Natl Acad Sci U S A. 2010 May 11;107(19):8766-71 – reference: 3029758 - Proc Natl Acad Sci U S A. 1987 Feb;84(4):1005-9 – reference: 16912290 - J Virol. 2006 Sep;80(17):8390-401 – reference: 3006059 - Proc Natl Acad Sci U S A. 1986 Mar;83(6):1627-31 – reference: 21575146 - Virol J. 2011;8:231 – reference: 51345 - Lancet. 1975 Sep 20;2(7934):528-30 – reference: 18201741 - Toxicol Appl Pharmacol. 2008 Apr 1;228(1):93-104 |
SSID | ssj0023352 |
Score | 2.1659987 |
Snippet | AIM:To observe the effect of vincristine on hepatitis B virus(HBV) replication in vitro and to study its possible mechanisms.METHODS:Vincristine was added to... To observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms. Vincristine was added to the... To observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms.AIMTo observe the effect of... AIM: To observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms. METHODS: Vincristine was added... |
SourceID | pubmedcentral proquest pubmed crossref chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1498 |
SubjectTerms | Antineoplastic Agents - pharmacology Apoptosis - drug effects Basic Study Cell Proliferation - drug effects Cell Survival - drug effects chemotherapy;Cell cyc DNA Replication - drug effects DNA, Viral - biosynthesis Dose-Response Relationship, Drug Hep G2 Cells Hepatitis B Core Antigens - metabolism Hepatitis B e Antigens - metabolism Hepatitis B Surface Antigens - metabolism Hepatitis B virus - drug effects Hepatitis B virus - genetics Hepatitis B virus - growth & development Hepatitis B virus - immunology Humans Liver Neoplasms - pathology Liver Neoplasms - virology reactivation;Cytotoxic RNA, Viral - biosynthesis S Phase Cell Cycle Checkpoints - drug effects Time Factors Transfection Vincristine - pharmacology Viral Virus Activation - drug effects Virus Replication - drug effects |
Title | S-phase arrest after vincristine treatment may promote hepatitis B virus replication |
URI | http://lib.cqvip.com/qk/84123X/201505/90888889504849534853484953.html https://www.ncbi.nlm.nih.gov/pubmed/25663769 https://www.proquest.com/docview/1653128756 https://pubmed.ncbi.nlm.nih.gov/PMC4316092 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKeOEFgbh1bMhIPCCNhNzsJI8MbUyjjAdS0TcrcZw2CNLRJkPw6znHTtJ0FGlQqVHkOk6V78u52MfnEPKCBTJ0gqKwXAUwBDJVVspDboUcrBHPj1Wsoyo_XPCzaXA-Y7PR6P0gaqmpM1v-2rmv5H9QhTbAFXfJ_gOy_aDQAOeALxwBYTjeCONP1uUCtNBRqitstPW-r8pK6jcXzMdNGPm39CfGYgEwCoxDDKOuy_XRMfReNXrloJu8G1qrJtJmkFxinq7r1RLTeK5M7iacUPh83tfnmjXaz1flJmxDr36oVj_2Xd4N-KSJVCprUg6nIFy9pdvUqjWSygOxZ4GeMwssakdbK2rNZuiWUmwgN8FPi3YJdEyOAyj8-DK3rzzXLpnd9dxOnX3xUZxOJxORnMySW-S2Bz6D303dtN43bi7DSoPd_zJ5nvAGr68Nj2k2Fstq_h2Mh21z5Q8f5Hoo7cA2Se6Ru61TQd8YhtwnI1U9IEnLDmrYQTU76IAdtGcHBXbQlh20Zwc9ppoddMCOh2R6epK8PbPaGhqWDPywthgr4jwKUjT7wzhjTp6jCQvPx8mLzJOpjLM88oocN_SEYN0p7udhqDLpSvDMpf-I7FXLSj0hVBYujyQDnyBjAXdk5HPJFVOsyLAspBqTV_1jE5cmV4rAMDr4xAw0BYYyBxF-8WxM7O7JCtnmo8eyKF8F-KUIiwBYBMAiSiYQljF52V_QDf_Xrs87qASIS1wDSyu1bNbC5aB0PHDS-Zg8NtD1g4H1z0HfxmMSboHad8BU7Nu_VOVCp2THhBJO7O3f4L5PyZ3NO3RA9upVow7BsK2zZ5qwvwE58KV_ |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=S-phase+arrest+after+vincristine+treatment+may+promote+hepatitis+B+virus+replication&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Xu%2C+Lei&rft.au=Tu%2C+Zeng&rft.au=Xu%2C+Ge&rft.au=Hu%2C+Jie-Li&rft.date=2015-02-07&rft.issn=2219-2840&rft.eissn=2219-2840&rft.volume=21&rft.issue=5&rft.spage=1498&rft_id=info:doi/10.3748%2Fwjg.v21.i5.1498&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg |